Daniel Gillon represents public and private companies in corporate and securities matters, including private financings, public offerings, mergers and acquisitions, SEC reporting and compliance, and corporate governance. He also advises biotechnology, pharmaceutical, and other life sciences companies on licensing and commercial agreements.
